High METTL1 expression is strongly associated with postoperative recurrence in AM, and knocking down METTL1 inhibits the proliferation, migration and invasion of AM cells both in vitro and in vivo. The gene discussed is METTL1; the disease is acute myeloblastic leukemia with maturation.